文献速递血管炎

巨细胞动脉炎狭窄性大血管受累的预后与长期结局

Prognosis and Long-Term Outcome of Stenotic Large Vessel Involvement in Giant Cell Arteritis.
PubMed 文献 · Arthritis Rheumatol · 2026-03-25

这项回顾性多中心研究纳入3149例巨细胞动脉炎(GCA)患者,其中198例(6.3%)存在狭窄性大血管炎(LVV)。狭窄性LVV主要累及锁骨下动脉(63%)、颈动脉(58%)等,卒中(31%)为主要并发症;血管并发症1、5、10年累积发生率分别为13.1%、17.3%、19.5%。诊断时年龄和椎动脉受累与血管并发症风险升高独立相关。

要点

  • 狭窄性LVV占GCA的6.3%,主要累及锁骨下动脉、颈动脉和椎动脉。
  • 卒中是最常见并发症(31%),血管并发症10年累积发生率达19.5%。
  • 诊断时年龄和椎动脉受累是血管并发症的独立危险因素。

核心结论

  • 狭窄性LVV占GCA不足10%,与不良血管预后相关。

研究设计与样本

  • 回顾性多中心研究纳入3149例GCA患者,其中198例(6.3%)为狭窄性LVV。
  • 对基线动脉定位行主成分层次聚类,并用逻辑回归评估血管并发症相关因素。

主要发现

  • 狭窄性LVV主要累及锁骨下动脉(63%)、颈动脉(58%)、椎动脉(37%)、腋动脉(33%),其次为股动脉(30%)和肠系膜动脉(13%)。
  • 卒中(31%)为主要并发症,其次为肢体缺血(21%)、心肌梗死(4%)和肠系膜缺血(2%)。
  • 血管并发症1、5、10年累积发生率分别为13.1%(95%CI 8.9-18.3)、17.3%(95%CI 12.3-22.9)、19.5%(95%CI 14.3-25.4)。
  • 聚类分析识别出3个聚类,其中聚类1(n=123;62%)包括年龄更大、前部缺血性视神经病变更多(P=0.04)、椎动脉狭窄及死亡率更高的患者(P<0.044)。
  • 多变量分析中,诊断时年龄(HR 1.06,95%CI 1.03-1.10;P=0.0004)和椎动脉受累(HR 1.87,95%CI 1.03-3.40;P=0.039)与血管并发症风险升高显著相关。

临床怎么用

  • 对GCA患者应评估大血管狭窄受累,尤其关注锁骨下动脉、颈动脉和椎动脉。
  • 诊断时年龄较大或椎动脉受累的患者可能需更密切监测血管并发症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Large vessel-vasculitis (LVV) accounts for up to 70% of patients with giant cell arteritis (GCA). Stenotic involvement in GCA-LVV remains largely unknown. The purpose of this study was to assess the long-term outcome and prognosis of GCA with stenotic LVV. METHODS: This was a retrospective multicenter study of 3,149 patients with GCA, including 198 (6.3%) with stenotic LVV. Hierarchical clustering on principal components was performed on baseline arterial localizations and logistic regression assessed factors associated with vascular complications. RESULTS: Stenotic LVV affected mostly the subclavian artery (63%), the carotid artery (58%), vertebral artery (37%), and axillary artery (33%), followed by the femoral artery (30%) and mesenteric arteries (13%). Stroke (31%) was the main complication, followed by limb ischemia (21%), myocardial infarction (4%), and mesenteric ischemia (2%). Cumulative incidence of vascular complications was 13.1% (95% confidence interval [CI] 8.9-18.3), 17.3% (95% CI 12.3-22.9), and 19.5% (95% CI 14.3-25.4), at 1, 5, and 10 years, respectively. Hierarchical clustering analysis identified three clusters among which cluster 1 (n = 123; 62%) included older patients with more arteritic anterior ischemic optic neuropathy (P = 0.04), vertebral artery stenosis, and a higher mortality rate (P < 0.044). In multivariate analysis, age at diagnosis (hazard ratio [HR] 1.06, 95% CI 1.03-1.10; P = 0.0004) and vertebral involvement (HR 1.87, 95% CI 1.03-3.40; P = 0.039) were significantly associated with higher risk of vascular complication. CONCLUSION: Stenotic LVV accounts for less than 10% of GCA and is associated with poor vascular prognosis.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Maalouf G, Arnould B, Espitia O, et al. Prognosis and Long-Term Outcome of Stenotic Large Vessel Involvement in Giant Cell Arteritis. Arthritis Rheumatol. 2026. PMID: 41728983. doi:10.1002/art.70101

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。